Reporting and analysis of immunotherapy trials adverse events: what is going wrong, how to do better?

Ann Oncol. 2024 Mar 26:S0923-7534(24)00083-8. doi: 10.1016/j.annonc.2024.03.006. Online ahead of print.NO ABSTRACTPMID:38548063 | DOI:10.1016/j.annonc.2024.03.006

Source: Ann Oncol - March 28, 2024 Category: Cancer & Oncology Authors: I Pourmir R Nebbache S Champiat O Lambotte Cancer Immunotherapy Adverse Events Working Group Source Type: research